BioCentury

New Therapeutic Targets and Biomarkers: June 2017

by BC Staff

New Therapeutic Targets and Biomarkers: June 2017

Select top therapeutic targets and biomarkers covered by BioCentury or added to the BCIQ database during June 2017. Therapeutic targets are defined as any protein, gene or other molecule that is the focus of a clinical or preclinical program, or that has been selected from the academic literature for coverage in the Distillery section of BioCentury Innovations, based on demonstration of translational potential in relevant preclinical assays. Biomarkers are defined as any protein, gene or other molecule that can be used as an indicator or predictor of pathogenic processes or pharmacologic responses. Entries include only human molecules or markers, or pathogenic molecules that can be targeted to treat human diseases. The list excludes targets or biomarkers for existing therapeutics and well-established targets from the literature. Targets previously listed in coverage of the meeting of the American Society of Clinical Oncology (ASCO) are excluded. Institutions mentioned represent the affiliations of the corresponding authors on the relevant study covered in the Distillery. Full details from BioCentury’s coverage of each target can be obtained from the link in the Notes column. Source: BCIQ: BioCentury Online Intelligence; BioCentury Archives